87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Appoints Experienced Mental Health Professional Senator Dr. Saphire Longmore M.B.B.S., DM As Chief Medical Officer Of Caribbean Affairs
10 nov. 2021 08h30 HE | Mycotopia Therapies Inc.
MIAMI, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”) today announced the appointment of Saphire Longmore M.B.B.S., DM, to the role of Chief Medical...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021
04 nov. 2021 08h30 HE | Mycotopia Therapies Inc.
MIAMI, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc., (OTC Pink: TPIA) (the “Company”), announced today that Ben Kaplan, President, Chief Executive Officer and Chairman, has issued a...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Signs Agreement With Havn Life Sciences For Purchase of Psilocybin SPP
25 août 2021 08h00 HE | Mycotopia Therapies Inc.
MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc. (OTC Pink: TPIA) (the “Company”), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin...
87520785_101152591495741_6497961433500745728_o.jpg
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
14 juil. 2021 08h30 HE | Mycotopia Therapies Inc.
MIAMI, July 14, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC Pink: TPIA) ("Mycotopia" or the “Company”) announced today that on July 13, 2021 Wesana Health Holdings Inc. (“Wesana”) (CSE:...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies PsyTech Inc. Announces Third Annual Psytech Summit on July 19th and 20th, 2021
02 juil. 2021 08h30 HE | Mycotopia Therapies Inc.
MIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC Pink: TPIA) (the “Company”) announced today an upcoming complimentary Psychedelic Industry summit will take place virtually...
87520785_101152591495741_6497961433500745728_o.jpg
UPDATE -- Mycotopia Therapies Inc. Begins Trading Under Symbol TPIA
04 mai 2021 10h15 HE | Mycotopia Therapies Inc.
MIAMI, May 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc., (OTC Pink: TPIA), a company focused on psychedelic therapies, announced today its name and symbol change are complete. Mycotopia...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Inc. Begins Trading Under Symbol MYCO
04 mai 2021 07h30 HE | Mycotopia Therapies Inc.
MIAMI, May 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc., (OTC Pink: MYCO), a company focused on psychedelic therapies, announced today its name and symbol change are complete. Mycotopia...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics
08 févr. 2021 08h30 HE | 20/20 Global, Inc.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies (20/20 Global, Inc.), (OTC Pink: TWGL), a company focused on psychedelic therapies, is establishing a biosynthetic compound subsidiary...
87520785_101152591495741_6497961433500745728_o.jpg
20/20 Global Announces It Has Applied for a Name and Stock Symbol Change with FINRA
08 févr. 2021 08h00 HE | 20/20 Global, Inc.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) “Mycotopia”, a company focused on psychedelic therapies, announced today that it has applied to the Financial Industry...